How TO AVOID a rectosigmoid resection in advance ovarian cancer? Hudson procedure in 10 steps.
ESGO eAcademy, Session Speakers, 274171
Symptom control and pain management (palliative care)
ESGO eAcademy, Cristina Sessa, 274581
Management of surgical complications
ESGO eAcademy, Christina Fotopoulou, 274582
Supportive care and management of side effects of systemic therapy
ESGO eAcademy, Mansoor Mirza, 274583
Surgical management of primary and recurrent ovarian cancer
ESGO eAcademy, Denis Querleu, 274585
Adjuvant treatment in early, advanced and recurrent ovarian cancer
ESGO eAcademy, Mansoor Mirza, 274586
Diagnosis and staging of ovarian cancer
ESGO eAcademy, Kamil Zalewski, 274587
Management of non-epithelial ovarian malignancies
ESGO eAcademy, Cristina Sessa, 274588
Primary treatment of early stage vulvar cancer
ESGO eAcademy, Kamil Zalewski, 274567
Management of advanced stage and recurrent vulvar cancer
ESGO eAcademy, Elżbieta Van Der Steen, 274568
Surgical management of endometrial cancer
ESGO eAcademy, Denis Querleu, 274572
Adjuvant treatment of endometrial cancer and recurrent disease
ESGO eAcademy, Cristina Sessa, 274573
Video: laparoscopic paraaortic lymphadenectomy (trans, retroperit.)
ESGO eAcademy, Ignacio Zapardiel, 274574
Video: open paraaortic lymphadenectomy
ESGO eAcademy, Christina Fotopoulou, 274575
Fertility preserving options in endometrial cancer
ESGO eAcademy, Ignacio Zapardiel, 274576
Breast cancer
ESGO eAcademy, Fedro Peccatori, 274577
Diagnosis and management of uterine sarcoma
ESGO eAcademy, Ignacio Zapardiel, 274578
Familial Gynaecological Cancer - risk assessment and management
ESGO eAcademy, Fedro Peccatori, 274579
Perioperative care
ESGO eAcademy, Christina Fotopoulou, 274580
Surgical spaces, lymphatic drainage, nerves, topography
ESGO eAcademy, Denis Querleu, 274557
Histopathology and immunohistochemistry
ESGO eAcademy, Petr Škapa, 274558
Principles of radiotherapy
ESGO eAcademy, Elżbieta Van Der Steen, 274559
Ultrasound, MRI in cervical cancer
ESGO eAcademy, Daniela Fischerova, 274560
Management of early invasive carcinoma (Stage IA1, IA2, IB1, IIA1)
ESGO eAcademy, David Cibula, 274561
Management of locally advanced cervical carcinoma (IB2, >IIA2)
ESGO eAcademy, Lukas Rob, 274562
Management of primary metastatic, persistent and recurrent Cx ca.
ESGO eAcademy, Elżbieta Van Der Steen, 274563
Video of laparoscopic pelvic lymphadenectomy
ESGO eAcademy, Ignacio Zapardiel, 274564
Video of radical hysterectomy (including nerve sparing)
ESGO eAcademy, David Cibula, 274565
Fertility sparing procedures in cervical carcinoma
ESGO eAcademy, Michael J. Halaška, 274566
Ultrasound in Endometrial Cancer
ESGO eAcademy, Juan Luis Alcázar, 273567
Pelvic exenterations
ESGO eAcademy, David Cibula, 273264
ESGO eAcademy, Dr. Gabriele Calaminus and Dr. Philippe Morice, 272307
Laparoscopic Extra-Peritoneal Aortic Dissection
ESGO eAcademy, Daniel Dargent, 272228
Discussion of the LION research
ESGO eAcademy, Prof. Querleu & Dr. Harter, 265912
Risk reduction surgery in gynaecological oncology
ESGO eAcademy, Ranjit Manchanda, 265913
New Surgical Aspects Of Lymph Node Dissection
ESGO eAcademy, Jalid Sehouli, 265933
Role of Lymph Node Dissection in Early Stage Ovarian Cancer
ESGO eAcademy, Bill Cliby, 265932
Prediction of Surgical Outcome: Tumor Biology vs. Surgical Skills
ESGO eAcademy, Elena Ioana Braicu, 265931
The Role of Secondary Cytoreduction in Ovarian Cancer
ESGO eAcademy, Thomas J. Herzog, 265930
Early Stage Cervical Cancer: Is Minimal Invasive Surgery Harming?
ESGO eAcademy, Giovanni Scambia, 265929
Surgery for recurrent ovarian cancer: Already a valid option now!?
ESGO eAcademy, Andreas du Bois, 265928
HIPEC for ovarian cancer: HYPE or HOPE?
ESGO eAcademy, Christina Fotopoulou, 265927
Early stage cervical cancer: MIS can be harmful!
ESGO eAcademy, David Cibula, 265926
Saling´s technique of Saling closure
ESGO eAcademy, Daniel Dargent, 261942
Nerve sparing laparoscopy radical hysterectomy made easy
ESGO eAcademy, Shailesh Puntambekar, 261717
Historical trachelectomy
ESGO eAcademy, Denis Querleu, 261701
Gestational Trophoblastic Disease; Updates for today's Gynae-Oncologist
ESGO eAcademy, Michael Seckl, 265463
Primary HPV DNA Screening and Results of 4 Million Females
ESGO eAcademy, Murat Gultekin, 259725
ESGO eAcademy, Philippe Morice, 259729
Neoadjuvant chemotherapy in advanced cervical cancers to preserve fertility? Is this safe?
ESGO eAcademy, Jalid Sehouli, 257715
What is the optimal management in fertility preservation in stage IB1 cervical cancer > 2 cm”
ESGO eAcademy, Philippe Morice, 257714
Treatment of gynae cancers during pregnancy
ESGO eAcademy, Alexandros Rodolakis, 257713
Fertility reserves after cytotoxic chemotherapy for gynaecological cancers and how to reduce toxicity
ESGO eAcademy, Christina Fotopoulou, 257712
Sexuality and psychooncological support in young women with cancer
ESGO eAcademy, Jalid Sehouli, 257711
Fertility options and reserves after pelvic radiotherapy.
ESGO eAcademy, David Cibula, 257710
Trachelectomy in pregnancy
ESGO eAcademy, Alexandros Rodolakis, 257709
Trachelectomy versus cone? Is less enough after all?
ESGO eAcademy, David Cibula, 257708
Safety of assisted reproductive options in patients with epithelial and non epithelial ovarian neoplasms
ESGO eAcademy, Philippe Morice, 257707
Fertility sparing approach in low grade and borderline lesions
ESGO eAcademy, Christina Fotopoulou, 257706
Minimal invasive surgery in early ovarian cancer: is it safe not to open?
ESGO eAcademy, Philip Harter, 257705
Preoperative patients consultation for 2-stage procedure and theatre planning
ESGO eAcademy, Christina Fotopoulou, 257704
Uterine transplantation in cancer patients
ESGO eAcademy, Richard Smith, 257703
Ovarian conservation in endometrial cancer and uterine sarcomas
ESGO eAcademy, Philippe Morice, 257702
Conservative treatment options for complex atypical hyperplasia and early invasive cancer: how safe is it to wait?
ESGO eAcademy, Eric Leblanc, 257701
Ideal imaging prior to trachelectomy for early cervical cancer: how to exclude high risk patients?
ESGO eAcademy, Alexandros Rodolakis, 257700
How has the definition and characterization of Borderline tumor definition evolved over time?
ESGO eAcademy, Philip Harter, 257699
Ultrasound: how can the IOTA rules differentiate pelvic masses to direct surgical radicality? Comparison to MRI features
ESGO eAcademy, Tom  Bourne, 257698
Fertility sparing management in cervical cancer
ESGO eAcademy, Michael J. Halaška, 257531
ESGO eAcademy, Virginia Benito, 257459
ESGO Guidelines for Cervical Cancer
ESGO eAcademy, Karl Tamussino, 256994
Fertility sparing
ESGO eAcademy, Ignacio Zapardiel, 256993
ESGO Surgical Guidelines for Ovarian Cancer
ESGO eAcademy, Denis Querleu, 256992
Best of ESGO 2017
ESGO eAcademy, Cristina Sessa, 256991
Hudson Procedure
ESGO eAcademy, Philippe Morice, 256990
Liver mobilization II
ESGO eAcademy, Luis M. Chiva, 256989
Liver mobilization I
ESGO eAcademy, Luis M. Chiva, 256988
Cardiophrenic nodes
ESGO eAcademy, Luis M. Chiva, 256987
Teaching Methodology for the Training of Laparoscopy
ESGO eAcademy, Denis Querleu, 256964
Complete removal of stage Iiic/IV adnexal cancer, pushing the envelope
ESGO eAcademy, Christina Fotopoulou, 256963
How to patent a new medical entity for clinical use (diagnostic test, medicinal product or medical device)
ESGO eAcademy, Ivo De Baere, 234634
How to write a grant application for a European call for proposal: the ENGOT experience.
ESGO eAcademy, Gennaro Daniele, 234633
Combining surgery and translational research in gynaecologic oncology; opportunities and obstacles
ESGO eAcademy, Christina Fotopoulou, 234632
How to prepare a study protocol. To do and not to do
ESGO eAcademy, Cristina Sessa, 234631
Applications challenges of the new EU clinical trials regulations
ESGO eAcademy, Gennaro Daniele, 234630
How to set up a collaborative group and coordinate a cooperative group at the European level (based on the experience of MITO and ENGOT group): requirements and challenges.
ESGO eAcademy, Gennaro Daniele, 234629
Role of the training abroad, importance of networking and building a strong network across Europe, building your career after a fellowship
ESGO eAcademy, Christina Fotopoulou, 234628
Maintenance therapy versus treatment
ESGO eAcademy, Mansoor Raza Mirza, 234645
Management of preinvasive cervical lesions
ESGO eAcademy, Vesna Kesic, 234584
Ultrasound, MRI, PET-CT, SLNM (clinical staging in cervical cancer)
ESGO eAcademy, Lukas Rob, 234585
Management of early invasive carcinoma (Stage IA1, IA2, IB1, IIA1)
ESGO eAcademy, Denis Querleu, 234586
Management of advanced cervical carcinoma (IB2, IIA2)
ESGO eAcademy, Denis Querleu, 234587
Management of advanced cervical carcinoma (Stage II and higher)
ESGO eAcademy, Isabel Rodríguez, 234588
Vulvar flaps, vaginectomy
ESGO eAcademy, Ate G.J. van der Zee, 234600
GTD - histology, presenattion and early surgical management
ESGO eAcademy, Frederic Goffin, 234601
HCG measurement in Gestational Trophoblastic Disease (GTD)
ESGO eAcademy, Ranjit Manchanda, 234602
Management of Gestional Trophoblastic disease (GTD
ESGO eAcademy, Frederic Goffin, 234603
Histopathology and carcinogenesis of ovarian cancer
ESGO eAcademy, Jurgen Piek, 234619
Management of early stage ovarian cancer
ESGO eAcademy, Fabrice Narducci, 234620
Video: debulking surgery in advanced ovarian cancer
ESGO eAcademy, Sonsoles Alonso, 234621
Management of advanced stage ovarian cancer
ESGO eAcademy, Fabrice Narducci, 234622

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings